Graham Capital Management, L.P. Castle Biosciences Inc Transaction History
Graham Capital Management, L.P.
- $5.08 Billion
- Q4 2024
A detailed history of Graham Capital Management, L.P. transactions in Castle Biosciences Inc stock. As of the latest transaction made, Graham Capital Management, L.P. holds 41,676 shares of CSTL stock, worth $916,038. This represents 0.02% of its overall portfolio holdings.
Number of Shares
41,676
Previous 15,676
165.86%
Holding current value
$916,038
Previous $447,000
148.32%
% of portfolio
0.02%
Previous 0.01%
Shares
9 transactions
Others Institutions Holding CSTL
# of Institutions
206Shares Held
25.8MCall Options Held
128KPut Options Held
35.4K-
Black Rock Inc. New York, NY3.04MShares$66.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.83MShares$40.3 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT1.8MShares$39.5 Million0.24% of portfolio
-
Principal Financial Group Inc Des Moines, IA1.44MShares$31.6 Million0.02% of portfolio
-
Dimensional Fund Advisors LP Austin, TX999KShares$22 Million0.01% of portfolio
About CASTLE BIOSCIENCES INC
- Ticker CSTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 26,297,000
- Market Cap $578M
- Description
- Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...